13 results on '"Vanhove B"'
Search Results
2. Effect of FR104, a Novel Anti-CD28 Fab, in Monkey Cardiac Allograft Transplantation.
3. Selective Blockade of CD28/B7/CTLA4 Pathway With Monovalent Anti-CD28 Versus Targeting of B7 With Belatacept, in Kidney Allograft in Non-Human Primate, After CNI Weaning.
4. Preclinical Efficacy and Immunological Safety of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in Humanized Mice Models
5. Blockade of T-Cell Homeostasis by Anti-Interleukin-7 Receptor Monoclonal Antibody Allows Indefinite Islet and Long-Term Skin Allograft Survival
6. Preclinical Evaluation of FR104, An Antagonist Anti-CD28 Monovalent Fabʼantibody, in DTH and Kidney Transplant Primates Models
7. COSTIMULATORY BLOCKADE DOES NOT PROMOTE SURVIVAL OF SKIN COMPONENT IN NON-HUMAN-PRIMATE COMPOSITE TISSUE ALLOGRAFTS
8. SELECTIVE CD28 INHIBITION PROLONGS GRAFT SURVIVAL AND ATTENUATES CAV IN MONKEY HEART RECIPIENTS TREATED WITH CD154 BLOCKADE
9. LONGTERM CLINICAL RECOVERY IN PARKINSONIAN MONKEY RECIPIENTS OF CTLA4-IG TRANSGENIC PORCINE NEURAL PRECURSORS
10. IMMUNOMODULATION INDUCED BY A CD28 ANTAGONIST IN KIDNEY ALLOGRAFT BABOON RECIPIENT.
11. ANTI-CD28 ANTIBODIES-MEDIATED SUPPRESSION OF ACUTE AND CHRONIC ALLOGRAFT REJECTION IS ASSOCIATED WITH THE PRESENCE OF REGULATORY CELLS AND WITH ANTI-DONOR CLASS II ANTIBODIES
12. CD40L AND CD28 BLOCKADE INDUCES REGULATORY MECHANISM AND INHIBITS CHRONIC ALLOGRAFT REJECTION
13. LATE XENOGRAFT REJECTION INVOLVES A STRONG T CELL RESPONSE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.